Institutional Ownership
Arcadia Biosciences Inc
CUSIP 039014303COMRKDAQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
5.0%
Max % of class reported
Institutional Holders
13
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Feb 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 14, 2024 | Armistice Capital, LLC | 13G/A | 5.0% | 58.3K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 159.4K | $220.0K |
| 2 | Sabby Management, LLC | 114.6K | $158.1K |
| 3 | Geode Capital Management, LLC | 31.7K | $43.8K |
| 4 | Susquehanna International Group, LLP | 12.6K | $17.4K |
| 5 | State Street Corp | 12.1K | $16.8K |
| 6 | Tower Research Capital LLC (Trc) | 3.9K | $5.4K |
| 7 | Ubs Group AG | 807 | $1.1K |
| 8 | Sbi Securities Co., Ltd. | 120 | $166 |
| 9 | Group One Trading LLC | 18 | $25 |
| 10 | Assetmark, Inc | 5 | $7 |